𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clozapine therapeutic plunge in patient with Parkinson's disease

✍ Scribed by Paul Greene


Book ID
118558034
Publisher
The Lancet
Year
1995
Tongue
English
Weight
303 KB
Volume
345
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clozapine in Parkinson's disease
✍ Peter Gonski; P. Auzou; D. Hannequin; N. Moore πŸ“‚ Article πŸ“… 1995 πŸ› The Lancet 🌐 English βš– 316 KB
Nocturnal akathisia in parkinson's disea
✍ Dr. G. Linazasoro; J. F. MartΓ­ MassΓ³; J. A. SuΓ‘rez πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 310 KB

## Abstract We present the results obtained using low doses of clozapine (mean dose 26.4 mg at bedtime) in the treatment of noctural akathisia in nine patients with Parkinson's disease for a mean period of 12.5 months. The results were excellent in all the patients. Furthermore, three patients expe

Clozapine-responsive tremor in Parkinson
✍ Dr. J. H. Friedman; M. C. Lannon πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 451 KB

## Abstract Clozapine is an atypical neuroleptic medication that is free of parkinsonian side effects and that has been reported to ameliorate the tremor of Parkinson's disease. We report (with videotape illustration) the dramatic improvement of severe yet classic rest tremors in one elderly nonpsy

Clozapine for psychosis in Parkinson's d
✍ Dr. Ronald F. Pfeiffer; Jasbir Kang; Benjamin Graber; Ruth Hofman; James Wilson πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 1 views

## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopa‐induced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5–25 mg daily, because